251 286 - Biotech Bayern
251 286 - Biotech Bayern
251 286 - Biotech Bayern
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Affectis Pharmaceuticals AG<br />
BIOTECH THERAPEUTICS & DIAGNOSTICS<br />
Keywords: Drug Development, RNAi & Antisense, Small Molecules, CNS<br />
Affectis is a biopharmaceutical company implementing novel concepts for the<br />
treatment of psychiatric disorders, especially depression and schizophrenia.<br />
Affectis has unique capabilities to discover and develop drugs based on pioneering<br />
findings in the field of psychiatric disorders. The Company’s drug discovery<br />
programme targets two interrelated pathways so far unknown in the context of<br />
depression and schizophrenia.<br />
The Company started operations in November 2003 as spin-off of the Max-Planck-<br />
Institute of Psychiatry (MPI) in Munich, Germany.<br />
Agrobiogen GmbH<br />
BIOTECH AGRO, FOOD, ENVIRONMENT<br />
Keywords: Agrobiotechnology, Transgenic Animals, Gene Transfer, Genomics,<br />
Xenotransplantation, Automation<br />
Agrobiogen focuses on and is experienced in the application of moleculargenetic<br />
techniques in livestock animals (especially moleculargenetic diagnosis<br />
and gene transfer). Many transgenic rabbit lines and serveral cattle clones have<br />
been established. As a service for other biotech companies transgenic farm<br />
animals are generated using conventional microinjection procedures and<br />
nucleus transfer. Gene diagnosis of microorganismus toxic to livestock like BVD,<br />
as well as parentage control of animals, scrapie resistance genotyping and<br />
analysis of DNA markers are offered as a service for breeders, veterinarians and<br />
companies. Agrobiogen has developed a simple labour-saving system for<br />
collection of tissue samples and extraction of DNA from millions of animals for<br />
automatically controlled analyses.<br />
ALGORA Gesellschaft für Medizinstatistik<br />
und Vertriebssysteme mbH<br />
CRO<br />
Keywords: Clinical Research, Monitoring, Analysis, Oncology, Infectious Diseases<br />
Algora is a niche CRO successfully operating on clinical trials in Germany.<br />
Services include phase II-IV trials as well as large observational studies and<br />
range from protocol development to final study reports. Algora manages complete<br />
study projects or delivers individual services, such as clinical monitoring,<br />
data management or statistical analysis. Experienced in oncology since the first<br />
days of the company in 1989, Algora always had a focus on innovative therapies,<br />
leading to close relationships to university hospitals and medical societies.<br />
Since 1995 another focus developed in large pediatric studies. Customers are<br />
pharmaceutical and medical device companies, independent research groups,<br />
and other CROs.<br />
Contact:<br />
Sabina van den Brandt<br />
Fraunhoferstr. 13 / 4. OG<br />
D-82152 Martinsried<br />
Phone: +49 (0) 89 8932811-0<br />
Fax: +49 (0) 89 8932811-111<br />
E-Mail: info@affectis.com<br />
Internet: www.affectis.com<br />
Contact:<br />
Prof. Dr. Gottfried Brem<br />
Thalmannsdorf 25, Larezhausen<br />
D-86567 Hilgertshausen<br />
Phone: +49 (0) 8250 928234<br />
Fax: +49 (0) 8250 928236<br />
E-Mail: monika.gutscher@agrobiogen.de<br />
Internet: www.agrobiogen.de<br />
Contact:<br />
Dr. Karl Fehnle<br />
Münchner Str. 11<br />
D-85540 Haar<br />
Phone: +49 (0) 89 6137270<br />
Fax: +49 (0) 89 61372720<br />
E-Mail: cro@algora.de<br />
Internet: www.algora.de<br />
39